IPOBoutique Brief – 1.13.2015

The IPO market will debut in 2015 this week with three deals on tap for the week:

• County Bancorp (Nasdaq: ICBK) is a Wisconsin corporation and registered bank holding company.
• Patriot National (NYSE: PN) – a national provider of comprehensive outsourcing solutions within the workers’ compensation marketplace for insurance companies, employers, local governments and reinsurance captives.
• Sutherland Asset Management (NYSE: SLD) is a real estate finance company that acquires, originates, manages, services and finances primarily small-balance commercial loans, or SBC loans.

We have IPO ratings, color and research available for these deals for a one-time fee of $50. Or check out looking into our annual subscription which is less than $83/month.

News this week will likely be dominated by the JP Morgan HealthCare Conference taking place in San Francisco. Leading up to the conference, a handful of mergers and acquisitions have been announced. When it comes to the IPO market, 37% of all IPOs that debuted in 2014 were in the HealthCare field and the buzz surrounding this event suggests that the sector is not slowing down.

“It is our belief that at the conclusion of the JP Morgan annual HealthCare Conference that it is highly likely that terms and launch dates will be assigned to those biotech and biomedical IPOs already in the pipeline,” senior managing partner of IPOBoutique.Com Scott Sweet said. “In addition, we also expect new filings to be initiated shortly after the conference conclusion.”

There is significant and historical financing news dealing with the biotech, Moderna Therapeutics. The company announced last week that it has raised $450 million in private funding making it the biggest biotech private round ever. Venture Capitalist and private funding may have reached a tipping point in the tech industry as there have been a handful of deals who have debuted below a previously privately financed valuation.

Zosano Pharma (Nasdaq: ZSAN) updated terms for its deal this past Friday but is in no rush to bring the deal out. The lead underwriter says there is no firm price date and they are looking at a ‘late January’ debut.